A Pennsylvania man, Larry Williams, has shown significant improvement in mobility after participating in an experimental drug trial for spinal cord injuries.
Williams, 58, was involved in a mountain biking accident where he struck a tree, causing paralysis due to a broken C4 to C6 vertebrae in his cervical spine.
The injection has helped him move more freely after his accident.
The experimental peptide drug, NVG-291, has been tested in a phase 2 trial with notable outcomes, including improved movement for patients with spinal cord injuries.
Author's summary: Experimental drug helps paralyzed man walk again.